Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Linde

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
CPT: Pharmacometrics & Systems Pharmacology|July 1, 2020
Population Pharmacokinetics and Exposure-Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic SyndromesNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.
Journal of Clinical Pharmacology|July 23, 2020
Population Pharmacokinetics and Exposure-Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β-ThalassemiaNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.
Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
Journal of the American Society of Nephrology : JASN|April 30, 2016
Overcoming Barriers in Kidney Health-Forging a Platform for InnovationPeter G Linde, Patrick Archdeacon, Matthew D Breyer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysisJustyna Siwy, Petra Zürbig, Angel Argiles, et al.
The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
The identification of orally bioavailable thrombopoietin agonistsMichael J Munchhof, Amy S Antipas, Laura C Blumberg, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
CPT: Pharmacometrics & Systems Pharmacology|July 1, 2020
Population Pharmacokinetics and Exposure-Response of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With Myelodysplastic SyndromesNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.
Journal of Clinical Pharmacology|July 23, 2020
Population Pharmacokinetics and Exposure-Response Relationship of Luspatercept, an Erythroid Maturation Agent, in Anemic Patients With β-ThalassemiaNianhang Chen, Nastya Kassir, Abderrahmane Laadem, et al.
Journal of Cardiac Failure|October 14, 2014
Risk factors for heart failure in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Danielle Wrolstad, George L Bakris, et al.
American Journal of Nephrology|June 7, 2014
Mechanisms contributing to adverse cardiovascular events in patients with type 2 diabetes mellitus and stage 4 chronic kidney disease treated with bardoxolone methylMelanie P Chin, Scott A Reisman, George L Bakris, et al.
Journal of the American Society of Nephrology : JASN|April 30, 2016
Overcoming Barriers in Kidney Health-Forging a Platform for InnovationPeter G Linde, Patrick Archdeacon, Matthew D Breyer, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|December 17, 2016
Noninvasive diagnosis of chronic kidney diseases using urinary proteome analysisJustyna Siwy, Petra Zürbig, Angel Argiles, et al.
The New England Journal of Medicine|March 31, 2021
Sotatercept for the Treatment of Pulmonary Arterial HypertensionMarc Humbert, Vallerie McLaughlin, J Simon R Gibbs, et al.
Bioorganic & Medicinal Chemistry Letters|February 3, 2009
The identification of orally bioavailable thrombopoietin agonistsMichael J Munchhof, Amy S Antipas, Laura C Blumberg, et al.
Bioorganic & Medicinal Chemistry Letters|August 21, 2007
Pyrimidine benzamide-based thrombopoietin receptor agonistsLawrence A Reiter, Chakrapani Subramanyam, Emilio J Mangual, et al.
The New England Journal of Medicine|March 27, 2020
A Phase 3 Trial of Luspatercept in Patients with Transfusion-Dependent β-ThalassemiaM Domenica Cappellini, Vip Viprakasit, Ali T Taher, et al.
Pageof 3